Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on August 1, 2017. The report discloses the Company's financial performance for the second fiscal quarter and the six months ended June 30, 2017. Note: The metadata provided lists "Clearpoint Neuro, Inc.", but the filing text explicitly identifies the registrant as "MRI Interventions, Inc."
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus prior periods. It serves as a notification that the Company has issued a press release regarding its Q2 and six-month results.
Guidance, Outlook, and Disclosures
- Regulation FD Disclosure: The Company posted an updated investor presentation to its website on August 1, 2017 (Exhibit 99.2).
- Forward-Looking Statements: The investor presentation contains summary information intended to be considered in the context of other SEC filings. The Company explicitly states it undertakes no duty or obligation to publicly update or revise the information in the presentation.
- Legal Status: Information in Items 2.02 and 7.01, including the exhibits, is not deemed "filed" under the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) by reviewing the full text of the Press Release (Exhibit 99.1) referenced in this filing.
- Confirm the details of the updated investor presentation (Exhibit 99.2) available on the Company's investor relations website.
- Note that the registrant name in the filing is MRI Interventions, Inc., not Clearpoint Neuro, Inc.